Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 1/6 |
4005 Stock Overview
National Medical Care Company engages in the business to establish, own, equip, operate, manage, and maintain healthcare facilities in the Kingdom of Saudi Arabia.
National Medical Care Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ر.س65.60 |
52 Week High | ر.س84.60 |
52 Week Low | ر.س50.70 |
Beta | 0.43 |
1 Month Change | 27.13% |
3 Month Change | -6.29% |
1 Year Change | -3.39% |
3 Year Change | 25.67% |
5 Year Change | 54.28% |
Change since IPO | -46.23% |
Recent News & Updates
National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Shareholder Returns
4005 | SA Healthcare | SA Market | |
---|---|---|---|
7D | 15.7% | -1.5% | 0.6% |
1Y | -3.4% | 12.6% | 18.3% |
Return vs Industry: 4005 underperformed the SA Healthcare industry which returned 15.6% over the past year.
Return vs Market: 4005 underperformed the SA Market which returned 20.6% over the past year.
Price Volatility
4005 volatility | |
---|---|
4005 Average Weekly Movement | 5.9% |
Healthcare Industry Average Movement | 4.6% |
Market Average Movement | 5.0% |
10% most volatile stocks in SA Market | 8.0% |
10% least volatile stocks in SA Market | 3.2% |
Stable Share Price: 4005 is not significantly more volatile than the rest of SA stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 4005's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | n/a | Abdulaziz Alobaid | https://www.care.med.sa |
National Medical Care Company engages in the business to establish, own, equip, operate, manage, and maintain healthcare facilities in the Kingdom of Saudi Arabia. The company operates Riyadh care hospital with a capacity of 325 beds; National hospital with a capacity of 459 beds; Family Health Care Center; and Care Company for Pharmaceutical and Medical Distribution. It also provides home healthcare services.
National Medical Care Fundamentals Summary
4005 fundamental statistics | |
---|---|
Market Cap | ر.س2.94b |
Earnings (TTM) | ر.س141.89m |
Revenue (TTM) | ر.س856.67m |
20.7x
P/E Ratio3.4x
P/S RatioIs 4005 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4005 income statement (TTM) | |
---|---|
Revenue | ر.س856.67m |
Cost of Revenue | ر.س605.53m |
Gross Profit | ر.س251.14m |
Other Expenses | ر.س109.24m |
Earnings | ر.س141.89m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 3.16 |
Gross Margin | 29.32% |
Net Profit Margin | 16.56% |
Debt/Equity Ratio | 0.0% |
How did 4005 perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yield32%
Payout RatioValuation
Is 4005 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 4005?
Other financial metrics that can be useful for relative valuation.
What is 4005's n/a Ratio? | |
---|---|
n/a Ratio | 0x |
n/a | n/a |
Market Cap | ر.س2.94b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.2x |
Enterprise Value/EBITDA | 13.2x |
PEG Ratio | 4x |
Price to Earnings Ratio vs Peers
How does 4005's PE Ratio compare to its peers?
4005 PE Ratio vs Peers |
---|
Company | PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 87x | ||
4009 Middle East Healthcare | 121.2x | 33.3% | ر.س3.1b |
2140 Ayyan Investment | 143.3x | n/a | ر.س1.5b |
4007 Al Hammadi Company For Development and Investment | 46.7x | 5.0% | ر.س6.7b |
4004 Dallah Healthcare | 36.8x | 14.6% | ر.س10.4b |
4005 National Medical Care | 20.7x | 5.2% | ر.س2.9b |
Price-To-Earnings vs Peers: 4005 is good value based on its Price-To-Earnings Ratio (20.7x) compared to the peer average (87x).
Price to Earnings Ratio vs Industry
How does 4005's PE Ratio compare vs other companies in the Asian Healthcare Industry?
Price-To-Earnings vs Industry: 4005 is good value based on its Price-To-Earnings Ratio (20.7x) compared to the SA Healthcare industry average (38.1x)
Price to Earnings Ratio vs Fair Ratio
What is 4005's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 20.7x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4005's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 4005 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 4005 (SAR65.6) is trading below our estimate of fair value (SAR86.13)
Significantly Below Fair Value: 4005 is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Future Growth
How is National Medical Care forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Future Growth Score
2/6Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
5.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4005's forecast earnings growth (5.2% per year) is below the savings rate (8.9%).
Earnings vs Market: 4005's earnings (5.2% per year) are forecast to grow faster than the SA market (-0.5% per year).
High Growth Earnings: 4005's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4005's revenue (5.5% per year) is forecast to grow faster than the SA market (-3.4% per year).
High Growth Revenue: 4005's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4005's Return on Equity is forecast to be low in 3 years time (12.6%).
Discover growth companies
Past Performance
How has National Medical Care performed over the past 5 years?
Past Performance Score
4/6Past Performance Score 4/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
22.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4005 has a high level of non-cash earnings.
Growing Profit Margin: 4005's current net profit margins (16.6%) are higher than last year (12.4%).
Past Earnings Growth Analysis
Earnings Trend: 4005 has become profitable over the past 5 years, growing earnings by 22.8% per year.
Accelerating Growth: 4005's earnings growth over the past year (35.4%) exceeds its 5-year average (22.8% per year).
Earnings vs Industry: 4005 earnings growth over the past year (35.4%) exceeded the Healthcare industry 0.6%.
Return on Equity
High ROE: 4005's Return on Equity (12.3%) is considered low.
Discover strong past performing companies
Financial Health
How is National Medical Care's financial position?
Financial Health Score
6/6Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: 4005's short term assets (SAR922.7M) exceed its short term liabilities (SAR252.6M).
Long Term Liabilities: 4005's short term assets (SAR922.7M) exceed its long term liabilities (SAR182.3M).
Debt to Equity History and Analysis
Debt Level: 4005 is debt free.
Reducing Debt: 4005 has no debt compared to 5 years ago when its debt to equity ratio was 25.5%.
Debt Coverage: 4005 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4005 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Dividend
What is National Medical Care current dividend yield, its reliability and sustainability?
Dividend Score
1/6Dividend Score 1/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Cash Flow Coverage
1.52%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 4005's dividend (1.52%) isn’t notable compared to the bottom 25% of dividend payers in the SA market (1.86%).
High Dividend: 4005's dividend (1.52%) is low compared to the top 25% of dividend payers in the SA market (4.28%).
Stability and Growth of Payments
Stable Dividend: 4005 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 4005 has only been paying a dividend for 9 years, and since then payments have fallen.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (31.6%), 4005's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 4005 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
2.7yrs
Average board tenure
CEO
Abdulaziz Alobaid
3.58yrs
Tenure
Dr. Abdulaziz Saleh Alobaid is the Chief Executive Officer at National Medical Care Company since January 1, 2019. He was the Chief Medical Officer at National Medical Care Company. He has the Canadian and...
Board Members
Experienced Board: 4005's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
National Medical Care Company's employee growth, exchange listings and data sources
Key Information
- Name: National Medical Care Company
- Ticker: 4005
- Exchange: SASE
- Founded: 2003
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: ر.س2.942b
- Shares outstanding: 44.85m
- Website: https://www.care.med.sa
Location
- National Medical Care Company
- Al Imam Ahmad Ibn hanbal Street
- Ar Rayyan Area
- Riyadh
- 11457
- Saudi Arabia
Listings
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/08/16 00:00 |
End of Day Share Price | 2022/08/16 00:00 |
Earnings | 2022/06/30 |
Annual Earnings | 2021/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.